Industry Keyword: Bioinformatics

Introduction The global pharmaceutical landscape is undergoing a profound transformation driven by the convergence of artificial intelligence and drug discovery. Traditional drug development processes, often characterised by high costs, protracted timelines, and high failure rates, are being reimagined through the adoption of AI-driven platforms. These technologies enable faster identification of viable drug candidates, predictive modelling of compound efficacy and toxicity, and optimisation of lead compounds with unprecedented efficiency. This study, which is available exclusively to Premium members, explores the emerging and...